0001209191-20-062100.txt : 20201207 0001209191-20-062100.hdr.sgml : 20201207 20201207213212 ACCESSION NUMBER: 0001209191-20-062100 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201203 FILED AS OF DATE: 20201207 DATE AS OF CHANGE: 20201207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hienrich Edi CENTRAL INDEX KEY: 0001472187 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32381 FILM NUMBER: 201374232 MAIL ADDRESS: STREET 1: 800 W. OLYMPIC BLVD., SUITE 406 CITY: LOS ANGELES STATE: CA ZIP: 90015 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HERBALIFE NUTRITION LTD. CENTRAL INDEX KEY: 0001180262 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: P.O. BOX 309GT STREET 2: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN STATE: E9 ZIP: 00000 BUSINESS PHONE: 310 410 9600 MAIL ADDRESS: STREET 1: P.O. BOX 309GT STREET 2: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN STATE: E9 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: HERBALIFE LTD. DATE OF NAME CHANGE: 20041214 FORMER COMPANY: FORMER CONFORMED NAME: WH HOLDINGS CAYMAN ISLANDS LTD DATE OF NAME CHANGE: 20020814 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-03 0 0001180262 HERBALIFE NUTRITION LTD. HLF 0001472187 Hienrich Edi 800 W. OLYMPIC BLVD. SUITE 406 LOS ANGELES CA 90015 0 1 0 0 SVP/Managing Director EMEA Common Stock 2020-12-03 4 M 0 15000 23.90 A 48529 D Common Stock 2020-12-03 4 F 0 10872 49.72 D 37657 D Common Stock 2020-12-03 4 M 0 26872 31.255 A 64529 D Common Stock 2020-12-03 4 F 0 21584 49.72 D 42945 D Common Stock 2020-12-04 4 S 0 6241 49.88 D 36704 D Common Stock 2020-12-07 4 S 0 9416 49.8756 D 27288 D Common Stock 13819 I By wife Stock Appreciation Rights 23.90 2020-12-03 4 M 0 15000 0.00 D 2018-05-07 2025-05-07 Common Stock 15000 0 D Stock Appreciation Rights 31.255 2020-12-03 4 M 0 26872 0.00 D 2019-05-09 2026-05-09 Common Stock 26872 0 D This transaction was executed in multiple trades at prices ranging from $49.87 to $49.88. The price reported reflects the weighted average sale price of $49.8756. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as part of an award covering 12,500 shares at an exercise price of $47.80 per share. The SARs were granted on May 7, 2015. 20% vested on May 7, 2016, 20% vested on May 7, 2017 and the remaining 60% vested on May 7, 2018. Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as part of an award covering 16,795 shares at an exercise price of $62.51 per share. The SARs were granted on May 9, 2016. 20% vested on May 9, 2017, 20% vested on May 9, 2018 and the remaining 60% vested on May 9, 2019. Lisa Kwon, as Attorney-in-Fact for Edi Hienrich 2020-12-07